AI Article Synopsis
- The study analyzed long-term clinical outcomes for 89 patients with salivary duct carcinoma (SDC), revealing a poor prognosis associated with the disease.
- Key findings indicated that the median age at diagnosis was 66 years and the 5-year overall survival rate was only 42%.
- Factors such as lymph node involvement, higher disease staging, and perineural invasion were significantly linked to worse survival outcomes and increased risk of distant metastasis.
Article Abstract
Purpose: This series reports long-term clinical outcomes of patients with salivary duct carcinoma (SDC), which is associated with a poor prognosis.
Methods And Materials: Eighty-nine patients with SDC were treated with curative intent from February 5, 1971, through September 15, 2018. Kaplan-Meier and competing risk analyses were used to estimate locoregional control, distant metastasis-free survival (DMFS), progression-free survival, and overall survival (OS). Cox regression analyses of disease and treatment characteristics were performed to discover predictors of locoregional control, DMFS, and OS.
Results: Median follow-up was 44.1 months (range, 0.23-356.67). The median age at diagnosis was 66 years (interquartile range, 57-75). Curative surgery followed by adjuvant radiation therapy was performed in 73 patients (82%). Chemotherapy was delivered in 26 patients (29.2%). The 5-year local recurrence and distant metastasis rates were 27% and 44%, respectively, with death as a competing risk. Distant metastasis was associated with lymph node-positive disease (hazard ratio [HR], 3.16; 95% confidence interval [CI], 1.38-7.23; = .006), stage IV disease (HR, 4.78; 95% CI, 1.14-20.11; = .033), perineural invasion (HR, 4.56; 95% CI, 1.74-11.97; = .002), and positive margins (HR, 9.06; 95% CI, 3.88-21.14; < .001). Median OS was 4.84 years (95% CI, 3.54-7.02). The 5-year OS was 42%. Reduced OS was associated with lymphovascular space invasion (HR, 3.49; 95% CI, 1.2-10.1; = .022), perineural invasion (HR, 2.05; 95% CI, 1.06-3.97; = .033), positive margins (HR, 2.7; 95% CI, 1.3-5.6; = .011), N2 disease (HR, 1.88; 95% CI, 1.03-3.43; = .04), and N3 disease (HR, 11.76; 95% CI, 3.19-43.3; < .001).
Conclusions: In this single-institution, multicenter retrospective study, the 5-year survival was 42% in patients with SDC. Lymphovascular space invasion, lymph node involvement, and higher staging at diagnosis were associated with lower DMFS and OS.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10157113 | PMC |
| http://dx.doi.org/10.1016/j.adro.2023.101204 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Article Synopsis
- The study measured fibrinogen fluorescence at temperatures between 20 and 80 degrees Celsius across different pH levels.
- It was found that raising the temperature from 20 to 40 degrees Celsius did not change the structure of fibrinogen in solutions with pH between 4.5 and 9.3.
- However, temperatures between 40 to 50 degrees Celsius caused some structural changes in neutral solutions, and temperatures above 50-55 degrees Celsius led to significant denaturation of the fibrinogen molecule.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!